Jornal Vascular Brasileiro
Jornal Vascular Brasileiro
Original Article

Long-term clinical and ultrasonographic evaluation of thrombophilic patients with deep venous thrombosis

Viviane Alessandra Capelluppi Tófano; Francisco Humberto Abreu Maffei; Hamilton Almeida Rollo; Marcone Lima Sobreira; Carlos Roberto Padovani; Isolete Tomazini Aparecida Santos

Downloads: 0
Views: 565


OBJECTIVE: The purpose of this study was to evaluate the long term clinical and ultrasonographic outcomes of thrombophilic patients with deep venous thrombosis (DVT).METHOD: Cohort study, retrospective case-control with cross-sectional analysis. Thirty-nine thrombophilic patients and 25 non-thrombophilic patients were assessed 76.3 ± 45.8 months after diagnosis. Demographic and family data were collected, as well as data from clinical and therapeutic progress, and physical and ultrasound examinations of the limbs were performed. Groups were matched for age and gender and the variables studied were compared across groups.RESULTS: Deep venous thrombosis was more frequent in women. The most common thrombophilias were antiphospholipid syndrome and factor V Leiden mutation. There was no difference between groups in terms of the number of pregnancies or miscarriages and the majority of women did not become pregnant after DVT. Non-spontaneous DVT prevailed. Proximal DVT and DVT of the left lower limb were more frequent, and the main risk factor was use of oral contraceptives. All patients were treated with anticoagulation. There was a higher frequency of pulmonary embolism in non-thrombophilic patients. Most patients considered themselves to have a "normal life" after DVT and reported wearing elastic stockings over at least 2 years. Seventy-one percent of patients had CEAP > 3, with no difference between groups. Deep venous reflux was more frequent in thrombophilic patients.CONCLUSION: There were no significant differences between groups with respect to most of the variables studied, except for a higher frequency of pulmonary embolism in non-thrombophilic patients and greater frequency of deep venous reflux in thrombophilic patients.


deep vein thrombosis, thrombophilia, postthrombotic syndrome, pulmonary embolism, duplex scan


Maffei FHA, Rollo HA. Trombose venosa profunda dos membros inferiores: incidência, patologia, fisiopatologia e diagnóstico. Doenças vasculares periféricas. 2002:1363-86.

Castro Silva M. Venous thromboembolism in the State of Minas Gerais and its projection to Brazil: Study based in 2,331,353 hospitalizations. Intern Angiol. 1997;16:193-6.

McLafferty RB, Lohr JM, Caprini JA. Results of the national pilot screening program for venous disease by the American Venous Forum. J Vasc Surg. 2007;45:142-8.

Geerts WH, Bergqvist D, Pineo GF. Prevention of Venous Thromboembolism. Chest. 2008;133:381S-453S.

Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-73.

Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet.. 2001;109:369-84.

Pomp ER, Cessie S, Rosendaal FR, Doggen CJM. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139:289-96.

D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1-11.

Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA. 2005;293:715-22.

Bank I, Middeldorp S, Büller HR. Hereditary and acquired thrombophilia. Semin Respir Crit Care Med. 2000;21:483-91.

Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-9.

Dahlbäck B. Resistance to activated protein C caused by the R 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med Suppl. 1997;242(740):1-8.

Pieroni F, Lourenço DM, Morelli VM, Maffei FH, Zago MA, Franco RF. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thromb Res. 2007;120(2):221-9.

Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-Untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703.

Morelli V, Lourenço DM, D'Almeida V. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis. 2002;13:271-5.

Pereira AC, Lourenço D, Maffei FH. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study). Thromb Res. 2007;119:183-8.

Graves M. Antiphosfolipid antibodies and thrombosis. Lancet. 1999;353:1348-53.

Genoud V, Castañon M, Annichino-Bizzacchi J, Korin J, Kordich L. Prevalence of three prothrombotic polymorphisms: fator V G1691A, fator II G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T in Argentina. Thromb Res. 2000;100:127-31.

Vossen C, Walker I, Svensson P. Recurrence rate after venous thrombosis in patients with familial thrombophilia. J Vasc Biol.. 2005;25:1992-7.

Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145(3):286-95.

Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454S-545S.

Spiezia L, Campello E, Giolo E, Villalta S, Prandoni P. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J ThrombHaemost. 2010;8:211-3.

Labropoulos N, Tiongson J, Pryior L. Definition of venous reflux in lower-extremity veins. J Vasc Surg. 2003;38:793-8.

Wilson W, Guaravi AE, Koike T. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an International Workshop. Arthritis Rheum. 1999;42:1309-11.

Goodman LA. Simultaneous confidence intervals for contrasts among multinomial populations. Ann Math Stat. 1964;35:716-25.

Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247-54.

Zar JH. Bioestatistical analysis. 1999.

Norman GR, Streiner DL. Bioestatistics - the bare essentials. 1994.

Brower JL, Veeger NJGM, Kluin-Nelemans HC, Van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med.. 2006;145:807-15.

Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors and recurrent venous thrombotic events. JAMA. 2005;293:2352-61.

Miyakis S, Lockshin MD, Atsumi T. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb. Haemost.. 2006;4:295-306.

Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupfermine MJ. Increase rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368-70.

Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Intern Med. 2004;164:558-63.

Pabinger R, Vormittag R. Thrombophilia and pregnancy outcomes. J Throm Haemost. 2005;3:1603-10.

Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF. Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod. 1999;14:2448.

Rai R. Obstetrical management of antiphospholipid syndrome. J Autoinmun. 2000;15:203-7.

Lijfering WM, Brower JLP, Veeger NJGM. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314-22.

Tosetto A, Rodeghiero F, Martinelli I. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation. Br J Haematol. 1998;103:8-50.

Martinelli I, Battaglioni T, Razzari C, Mannucci M. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Throm Haemost. 2007;5:98-101.

Prandoni P, Lensing AWA, Cogo A. The long-term clinical course of deep venous thrombosis. Ann Intern Med. 1996;125:1-7.

Brandjes DP, Baller HR, Heijboer H. Randomised trial of effect of compression stocking in patients with symptomatic proxinal-vein thrombosis. Lancet. 1997;349:759-62.

Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000;15:425-9.

Kahn SR, Kearon C, Julian JA. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005;3:718-23.

Pesavento R, Bernardi E, Concolato A, Dalla Vale F, Pagnan A, Prandoni P. Posstthrombotic syndrome. Semin Thromb Hemost. 2006;32:744-51.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5ddd89230e8825b1571da3e9 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections